Clinical trial
Preoperative Thalidomide With Radiation Therapy For Patients With Low-Grade…
NCT00089544 · National Cancer Institute (NCI), NIH · Terminated
Key facts
| NCT number | NCT00089544 |
|---|---|
| Title | Preoperative Thalidomide With Radiation Therapy For Patients With Low-Grade Primary Soft Tissue Sarcoma or Thalidomide With Radiation Therapy and Chemotherapy For Patients With High-Grade or Intermediate-Grade Primary Soft Tissue Sarcoma of the Arm, Leg, or Body Wall |
| Official title | A Pilot Phase II Study of Pre-Operative Radiation Therapy and Thalidomide (IND 48832; NSC 66847) for Low Grade Primary Soft Tissue Sarcoma or Pre-Operative MAID/Thalidomide/Radiation Therapy for High/Intermediate Grade Primary Soft Tissue Sarcoma of the Extremity or Body Wall |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Collaborators | Radiation Therapy Oncology Group |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Recurrent Adult Soft Tissue Sarcoma, Stage I Adult Soft Tissue Sarcoma AJCC v7, Stage II Adult Soft Tissue Sarcoma AJCC v7, Stage III Adult Soft Tissue Sarcoma AJCC v7 |
| Intervention type | Biological, Drug, Other, Procedure, Radiation |
| Interventions | Dacarbazine, Doxorubicin Hydrochloride, Filgrastim, Ifosfamide, Laboratory Biomarker Analysis, Radiation Therapy, Thalidomide, Therapeutic Conventional Surgery |
| Enrollment | 23 |
| Start date | Jun 17, 2004 |
| Primary completion | Sep 27, 2011 |
| Completion | Nov 5, 2013 |
| First posted | Aug 9, 2004 |
| Last update posted | Apr 13, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: